UCI statement on André Cardoso

The Union Cycliste Internationale (UCI) announces that Portuguese rider André Cardoso was notified of an Adverse Analytical Finding (AAF) of Erythropoietin in a sample collected in the scope of an out-of-competition control on 18 June 2017.

The control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling.

The rider has the right to request and attend the analysis of the B sample. In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair.